Diagonal Bio

Diagonal Bio is an early-stage diagnostics company based in Stockholm, Sweden, creating a novel point-of-care testing platform. Its proprietary Panviral technology enables the rapid development and deployment of tests that can detect multiple viruses in animals, such as horses, within 15 minutes. The company's approach combines speed, accuracy, and portability, targeting the veterinary diagnostics market with potential for expansion. It operates as a private entity, likely in a pre-revenue stage as it develops its platform and initial product offerings.

Patented Panviral diagnostic platform enabling rapid development of point-of-care tests that deliver results in under 15 minutes. Focuses on accuracy, speed, ease-of-use, and portability for on-site analysis.

The point-of-care diagnostics market is highly competitive, with large established players (e.g., Abbott, Roche, IDEXX) and numerous startups. Diagonal Bio must differentiate its platform on development speed, multiplexing capability, or cost to capture market share.